External Automatic Glaucoma Laser (EAGLE) for the first-line glaucoma treatment: Commercial prototype development and validation

Projektinformationen

GLAUrious

ID Finanzhilfevereinbarung: 720274

DOI 10.3030/720274

Projekt abgeschlossen

EK-Unterschriftsdatum 25 August 2016

Startdatum 1 September 2016

Enddatum 29 Februar 2020

Finanziert unter

• Horizon 2020 Framework Programme

Gesamtkosten € 4 036 138,25

EU-Beitrag € 2 480 275,00

Koordiniert durch

THE QUEEN'S UNIVERSITY OF BELFAST
United Kingdom

Leistungen

Websites, patent fillings, videos etc. (3)

Public website
Publication of at least five communicative press releases/papers/newsletters regarding the project results
Participation in at least five conferences

Documents, reports (10)

Report on planned communication activities
Report on ISO accreditation readiness
Interim report 2 of patients' recruitment, study implementation and clinical trial monitoring

Interim reports of patients' recruitment, study implementation and clinical trial monitoring

Report the final primary and secondary endpoints results assessments of FIH study

Report the final primary and secondary endpoints results assessments of FIH study

Report on clinicians workshop
Quality control plan
Finalized clinical protocol and investigator brochure submitted
Interim report 1 of patients' recruitment, study implementation and clinical trial monitoring

Interim reports of patients' recruitment, study implementation and clinical trial monitoring

Updates to the risk mitigation strategy
Report on study initiation and training of clinical sites

Demonstrators, pilots, prototypes (1)

Demonstrational prototypes produced

Other (1)

Report on DHF draft ready towards CE submission